Nifty Pharma index rises; Lupin, Cipla shares shine

NEW DELHI: Pharma shares were trading mixed with the Nifty Pharma index trading 0.2 per cent up at 9,663.1 around 12:12 pm on Monday.

Shares of Lupin (up 1.64 per cent), Cipla (up 1.24 per cent), Piramal Enterprises (up 1.03 per cent) and Cadila Healthcare (up 0.90 per cent) were among the top gainers in the index.

Biocon (down 1.67 per cent), Aurobindo Pharma (down 0.63 per cent), Glenmark Pharmaceuticals (down 0.63 per cent) and Sun Pharmaceutical Industries (down 0.14 per cent) were trading in the red.

Benchmark NSE Nifty50 index was down 9.40 points at 10,575.8 while BSE Sensex was down 79.56 points at 35,078.99 at that time.

Among the 50 stocks in the Nifty index, 21 were trading in the green, while 29 were in the red.

Shares of YES Bank, SBI, Tata Motors, Ashok Leyland, Titan Company, Bank of Baroda, ICICI Bank, Vedanta, HPCL and Cipla were among the most traded shares on the National Stock Exchange.

  • Related Posts

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?